M42, AstraZeneca sign agreement to advance prevention and precision medicine for breast cancer

M42, the global health powerhouse, has signed a groundbreaking agreement with AstraZeneca, a global leader in science-led biopharmaceuticals, to advance preventive healthcare and next-generation precision medicine.As AstraZeneca’s clinical genomics partner of choice in the Middle East region, M42 w